(Press-News.org) Washington, DC – A drug developed to treat Ewing's Sarcoma, a rare childhood cancer, may also help prevent human prostate cancer from spreading, as seen in new lab studies say researchers at Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center (GUMC).
Published online April 29 in PLoS ONE, the researchers report that if the agent continues to work well in further laboratory and preclinical studies, it may be the first prostate cancer drug specifically designed to stop cancer spread, or metastasis.
"This agent does not kill prostate cancer cells, but limits their ability to spread, which could be hugely beneficial in patients," says the study's lead investigator, Aykut Üren, M.D., an associate professor at Georgetown Lombardi. "This study is an early proof of principle that such an approach might be feasible in the clinic, but we have a lot of work to refine and test the drug."
The agent, YK-4 279, was designed in the GUMC Drug Discovery Program, directed by Milton Brown, M.D., Ph.D., a co-author on the paper. YK-4 279 is also being investigated for the treatment of Ewing's sarcoma and is expected to move quickly into a clinical study. Üren participated in the development of YK-4 279, an effort that was led by Georgetown Lombardi researcher Jeffrey Toretsky, M.D., also a co-author of this study.
Recent research has shown that 40 to 70 percent of prostate cancer cells express novel proteins when normal genes such as ETV1 and ERG break off from a chromosome and fuse in to a new location. These new genes produce proteins that push prostate cancer cells to become more aggressive and spread.
Noting that Ewing's sarcoma is produced by a similar fusion gene, the researchers decided to see if their drug would work in prostate cancer cells.
They applied the agent to prostate cancer cells with chromosomal translocations that expressed either an ERG protein or an ETV1 protein and found that the YK-4 279 did inhibit functions of these proteins, which reduced their motility and invasiveness. Tests in cancer cells that did not have either translocation show the agent had no effect.
The researchers also found that although the male hormone androgen turns on genes involved in progression of prostate cancer, including these fusions genes, the presence or absence of androgen is not necessary for this agent to work.
"That means, if successful, YK-4 279 could work in androgen sensitive prostate cancer cells or in cancer that has become resistant to androgen treatment," Üren says.
He says the agent will likely need to be reformulated for prostate cancer use since the fusion gene that causes the Ewing's sarcoma is similar but not identical to ones in prostate cancer.
###
Additional co-authors of this paper include Said Rahim, Elspeth Beauchamp, Ph.D., and Yali Kong, Ph.D.
The study was funded by Georgetown Lombardi's Cancer Center Support Grant from the National Cancer Institute, the Children's Cancer Foundation, Go4the Goal, Dani's Foundation, Alex's Lemonade Stand Foundation, Liddy Shriver Sarcoma Initiative, Burroughs Wellcome Clinical Scientist Award in Translational Research, and the National Institutes of Health.
Georgetown University has patent applications pending on YK-4 279 in the United States, Canada, Europe, and Australia on which Uren, Brown, Kong and Toretsky are inventors.
About Georgetown Lombardi Comprehensive Cancer Center
The Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Lombardi is one of only 40 comprehensive cancer centers in the nation, as designated by the National Cancer Institute, and the only one in the Washington, DC, area. For more information, go to http://lombardi.georgetown.edu.
About Georgetown University Medical Center
Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC's mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing & Health Studies, both nationally ranked; Georgetown Lombardi Comprehensive Cancer Center, designated as a comprehensive cancer center by the National Cancer Institute; and the Biomedical Graduate Research Organization (BGRO), which accounts for the majority of externally funded research at GUMC including a Clinical Translation and Science Award from the National Institutes of Health. In fiscal year 2009-2010, GUMC accounted for nearly 80 percent of Georgetown University's extramural research funding.
Investigational agent shows promise in reducing spread of prostate cancer
2011-04-30
ELSE PRESS RELEASES FROM THIS DATE:
Learn More About Florida's Child Abduction Prevention Act
2011-04-30
Learn More About Florida's Child Abduction Prevention Act
Florida's landmark Child Abduction Prevention Act (CAPA) was signed into law in January of this year. It is designed to give courts more power to act upon suspicions that a parent embroiled in a child custody dispute might attempt to take the child and flee to another state or country.
The law was authored and championed not by a lawmaker but by a Florida mom, Carolyn Vlk. She found herself in the unenviable position of a hotly contested divorce and feared that her husband -- a native of the Czech Republic ...
Mayo Clinic finds robotic surgery effective for removing hard-to-reach throat cancer
2011-04-30
ROCHESTER, Minn. -- Robotic surgery has become a mainstream tool for removing an ever-increasing variety of head and neck tumors. Now, a team of head and neck surgeons from Mayo Clinic has found robotic surgery can treat cancer in the narrow, hard-to-reach area beyond the tongue at the top of the voice box. Some patients were able to avoid further treatment with chemotherapy or radiation, and most could resume normal eating and speaking.
"We've known it's useful for tongue base and tonsil cancers, but we wanted to assess its effectiveness in the larynx," says Kerry ...
Dune Medical's MarginProbe demonstrates increased positive margin identification leading to reduction in patients indicated for re-excision in landmark lumpectomy surgery trial
2011-04-30
WASHINGTON, DC/FRAMINGHAM, MA, APRIL 29, 2011 – Dune Medical Devices, Inc. today announced that the landmark, 664-patient pivotal trial evaluating the MarginProbe™ System met its primary endpoints. The MarginProbe System provides surgeons with a real time, intraoperative technology to detect microscopically-positive margins on excised tissues. Top-line data from the study were presented at the 12th Annual Meeting of the American Society of Breast Surgeons (ASBS) in Washington, DC. Results showed that, when using MarginProbe in addition to standard of care techniques, there ...
Newberry South Carolina Hotel Provides Nearby Accommodations to Guests Attending May 2011 Commencement at Newberry College
2011-04-30
The Holiday Inn Express & Suites Newberry South Carolina Hotel offers convenient lodging to Newberry College's May Commencement Ceremony. The ceremony, which will honor approximately 150 graduating students, is scheduled to take place on May 7, 2011 in Eleazer Arena at 2:30pm. Tickets are required for admission. In addition, the Baccalaureate Service will be held at 11:00am in the Wiles Chapel.
Rudy Mancke, Environmentalist and PBS "NatureScene" host, is Newberry College's 2011 commencement speaker. Mancke is an adjunct faculty member and naturalist-in-residence ...
The rewards of doing 'something'
2011-04-30
People don't really care what they're doing—just as long as they are doing something. That's one of the findings summarized in a new review article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
When psychologists think about why people do what they do, they tend to look for specific goals, attitudes, and motivations. But they may be missing something more general - people like to be doing something. These broader goals, to be active or inactive, may have a big impact on how they spend their time.
Author ...
Researchers discover mechanism that could convert certain cells into insulin-making cells
2011-04-30
Simply put, people develop diabetes because they don't have enough pancreatic beta cells to produce the insulin necessary to regulate their blood sugar levels.
But what if other cells in the body could be coaxed into becoming pancreatic beta cells? Could we potentially cure diabetes?
Researchers from UCLA's Larry L. Hillblom Islet Research Center have taken an important step in that direction. They report in the April issue of the journal Developmental Cell that they may have discovered the underlying mechanism that could convert other cell types into pancreatic ...
Statement: The New York Stem Cell Foundation on lifting ban of federal funds for stem cell research
2011-04-30
The New York Stem Cell Foundation (NYSCF) applauds the US Court of Appeals for the District of Columbia's decision to dismiss District Court Judge Royce Lamberth's ruling against the use of public funds for embryonic stem cell research.
"This is an important day for stem cell research and the nation's scientific community. Most importantly, this is a victory for the patients around the world suffering from incurable diseases," says Susan L. Solomon, CEO of NYSCF, which is a leading voice in stem cell research, advocacy and policy; conducts groundbreaking scientific ...
Ongoing relationship with care provider key for patients with a chronic condition: UBC study
2011-04-30
People with a chronic condition such as diabetes or arthritis may find themselves taking on a more active role in maintaining or improving their own health if there is an ongoing relationship with a primary healthcare (PHC) provider, according to University of British Columbia research.
Appearing in the current issue of Medical Care, the study is the first in Canada to investigate the links between having a regular primary healthcare provider and patient activation, a growing direction in healthcare that aims to increase people's skills, confidence and knowledge so they ...
Debenhams Reveals The Best And Worst Wedding Dresses
2011-04-30
Debenhams has revealed which dressed have been voted the best and worst wedding dress by British Women.
British women favour the celebrity wedding dresses of yesteryear over the choices by more contemporary icons, according to Debenhams wedding list customers.
Jackie Onassis' Anne Lowe wedding dress was top of the frocks while Pamela Anderson's wedding outfit - a white bikini and sailor's hat - was voted the worst.
Ed Watson, spokesperson for Debenhams said: "When it comes to British taste, it's a case of something old over something new - half of the top ...
Black cardiac arrest patients more likely to be admitted to hospitals with lowest survival rates
2011-04-30
PHILADELPHIA – Black cardiac arrest victims are more likely to die when they're treated in hospitals that care for a large black population than when they're brought to hospitals with a greater proportion of white patients, according to new research from the University of Pennsylvania School of Medicine. The study is published in the April issue of the American Heart Journal.
The Penn team found that, among 68,115 cardiac arrest admissions analyzed through Medicare records, only 31 percent of black patients treated in hospitals that care for a higher proportion of black ...